References
- Maury C PJ, Teppo A-M, Eklund B, Hayry P, Ahonen J. Serum amyloid A levels in human allograft rejection. Clin Sci 1983; 65: 547
- Maury C PJ, Teppo A-M, Eklund B, Ahonen J. Serum amyloid A protein: A sensitive indicator of renal allograft rejection in humans. Transplantation 1983; 36: 501
- Häyry P, von Willebrand E, Ahonen J, Eklund B. Glucocorticoids in renal transplantation. Scand J Immunol 1982; 16: 39
- Häyry P, von Willebrand E. Monitoring of human renal allograft rejection with fine needle aspiration cytology. Scand J Immunol 1981; 13: 87
- Ehnholm C, Teppo A-M, Ohisalo J J, Maury C PJ. Human high-density lipoprotein associated amyloid A protein. Structural characteristics, relation to apoA-I and A-II concentrations, and plasma clearance kinetics in the rat. Scand J Rheumatol 1985; 14: 201
- Maury C PJ, Ehnholm C, Lukka M. Serum amyloid A protein subtypes in acute and chronic inflammatory conditions. Ann Rheum Dis 1985; 44: 411
- Selinger M J, McAdam KPWJ, Kaplan M M, Sipe J D, Vogel S N, Rosenstreich D L. Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Nature 1980; 285: 498
- McAdam KPWJ, Li J, Knowles J, Foss N T, Dinarello A, Rosenwasser L L, Selinger M J, Kaplan M M, Goodman R, Herbert P N, Bausserman L L, Nadler L M. The biology of SAA: Identification of the inducer, in vitro synthesis, and heterogeneity demonstrated with monoclonal antibodies. Ann NY Acad Sci 1982; 389: 126
- Sipe J D, Vogel S N, Sztein M B, Skinner M, Cohen A S. The role of interleukin 1 in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis. Ann NY Acad Sci 1982; 389: 137
- Ramadori G, Sipe J D, Dinarello C A, Mizel S B, Colten H R. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin-1 (IL-1) and purified human IL-1. J Exp Med 1985; 162: 930
- Hoffmann J S, Benditt E P. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA) in the mouse. J Clin Invest 1983; 71: 926
- Benson M D, Aldo-Benson M. Effect of purified SAA on immune response in vitro: Mechanisms of suppression. J Immunol 1979; 122: 2077
- Also-Benson M A, Benson M D. SAA suppression of immune response in vitro: Evidence for an effect on T cell-macrophage interaction. J Immunol 1982; 128: 2390
- McAdam KPWJ, Elin R J, Sipe J D, Wolff S M. Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest 1978; 61: 390
- Maury C PJ, Teppo A-M, Raunio P. Control of the acute phase serum amyloid A response. Comparison of total replacement of hip and knee. Eur J Clin Invest 1984; 14: 323
- Maury C PJ, Teppo A-M. Comparative study of serum amyloid-related protein SAA, C-reactive protein, and β2-microglobulin as markers of renal allograft rejection. Clin Nephrol 1984; 6: 284
- Maury C PJ. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sci 1985; 68: 233
- Maury C PJ, Teppo A-M, Ahonen J, von Willebrand E. Measurement of serum amyloid A protein concentrations as test of renal allograft rejection in patients with initially non-functioning grafts. Br Med J 1984; 288: 360
- Falck H M, Maury C PJ, Teppo A-M, Wegelius O. Persistently high serum amyloid A protein and Creactive protein levels correlate with rapid progression of secondary amyloidosis. Br J Med 1983; 286: 1391